These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35220855)

  • 1. Patients receiving hemodialysis do not lose SARS-CoV-2 antibodies more rapidly than non-renal controls: a prospective cohort study.
    Parshina E; Zulkarnaev A; Tolkach A; Ivanov A; Kislyy P; Gaipov A
    Ren Fail; 2022 Dec; 44(1):392-398. PubMed ID: 35220855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term antibody response after 1 dose of BNT162b2 vaccine in patients receiving hemodialysis.
    Goupil R; Benlarbi M; Beaubien-Souligny W; Nadeau-Fredette AC; Chatterjee D; Goyette G; Gunaratnam L; Lamarche C; Tom A; Finzi A; Suri RS;
    CMAJ; 2021 May; 193(22):E793-E800. PubMed ID: 33980499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular and humoral immune responses to COVID-19 booster vaccination in Japanese dialysis patients.
    Yoshifuji A; Toda M; Oyama E; Nakayama T; Mise-Omata S; Kikuchi K; Yoshizawa M; Kato N; Wakai H; Koibuchi K; Morimoto K; Uwamino Y; Namkoong H; Shibata A; Wakabayashi K; Fujino M; Komatsu M; Mochizuki N; Kondo N; Yoshimura A; Hasegawa N; Ryuzaki M
    Clin Exp Nephrol; 2024 Jul; 28(7):674-682. PubMed ID: 38457030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody Status, Disease History, and Incidence of SARS-CoV-2 Infection Among Patients on Chronic Dialysis.
    Cohen DE; Sibbel S; Marlowe G; Bludorn K; Miller D; Kelley T; Connaire J; Young A; Tentori F; Brunelli SM
    J Am Soc Nephrol; 2021 Aug; 32(8):1880-1886. PubMed ID: 34215666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodialysis patients with coronavirus disease 2019: reduced antibody response.
    Beppu H; Fukuda T; Kawanishi T; Yasui F; Toda M; Kimura H; Nakamura Y; Nakamura Y; Kojima K; Ogawa H; Ishiwatari A; Kamei Y; Ogawa T; Abe Y; Endo M; Hanawa T; Mizobuchi R; Sugita C; Okamoto K; Hatakeyama S; Yamada T; Kohara M; Wakai S
    Clin Exp Nephrol; 2022 Feb; 26(2):170-177. PubMed ID: 34487276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigating the utility of COVID-19 antibody testing in end-stage renal disease patients receiving haemodialysis: a cohort study in the United Kingdom.
    Wickens O; Chinnadurai R; Mannan F; Svendsen F; Baig MY; Chukwu C; Ali I; Summersgill C; Evans D; Antoine BV; Oxton J; Mairs N; Flanagan E; Oliver R; Kalra PA; Poulikakos D
    BMC Nephrol; 2021 Apr; 22(1):154. PubMed ID: 33902482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity of COVID-19 Tozinameran Vaccination in Patients on Chronic Dialysis.
    Schrezenmeier E; Bergfeld L; Hillus D; Lippert JD; Weber U; Tober-Lau P; Landgraf I; Schwarz T; Kappert K; Stefanski AL; Sattler A; Kotsch K; Dörner T; Sander LE; Budde K; Halleck F; Kurth F; Corman VM; Choi M
    Front Immunol; 2021; 12():690698. PubMed ID: 34276681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting.
    Li Z; Xiang T; Liang B; Deng H; Wang H; Feng X; Quan X; Wang X; Li S; Lu S; Yang X; Wang B; Zelinskyy G; Trilling M; Sutter K; Lu M; Dittmer U; Yang D; Zheng X; Liu J
    Front Immunol; 2021; 12():802858. PubMed ID: 35003131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the SARS-CoV-2 Antibody Response to the BNT162b2 Vaccine in Patients Undergoing Hemodialysis.
    Yau K; Abe KT; Naimark D; Oliver MJ; Perl J; Leis JA; Bolotin S; Tran V; Mullin SI; Shadowitz E; Gonzalez A; Sukovic T; Garnham-Takaoka J; de Launay KQ; Takaoka A; Straus SE; McGeer AJ; Chan CT; Colwill K; Gingras AC; Hladunewich MA
    JAMA Netw Open; 2021 Sep; 4(9):e2123622. PubMed ID: 34473256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Humoral and cellular response to SARS-CoV-2 BNT162b2 mRNA vaccine in hemodialysis patients.
    Melin J; Svensson MK; Albinsson B; Winqvist O; Pauksens K
    BMC Immunol; 2021 Oct; 22(1):70. PubMed ID: 34666683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2-specific B- and T-cell immunity in a population-based study of young Swedish adults.
    Björkander S; Du L; Zuo F; Ekström S; Wang Y; Wan H; Sherina N; Schoutens L; Andréll J; Andersson N; Georgelis A; Bergström A; Marcotte H; Kull I; Hammarström L; Melén E; Pan-Hammarström Q;
    J Allergy Clin Immunol; 2022 Jan; 149(1):65-75.e8. PubMed ID: 34695490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serial SARS-CoV-2 Receptor-Binding Domain Antibody Responses in Patients Receiving Dialysis.
    Anand S; Montez-Rath ME; Han J; Garcia P; Cadden L; Hunsader P; Kerschmann R; Beyer P; Boyd SD; Chertow GM; Parsonnet J
    Ann Intern Med; 2021 Aug; 174(8):1073-1080. PubMed ID: 34000201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetics of SARS-CoV-2 Specific and Neutralizing Antibodies over Seven Months after Symptom Onset in COVID-19 Patients.
    Zhu L; Xu X; Zhu B; Guo X; Xu K; Song C; Fu J; Yu H; Kong X; Peng J; Huang H; Zou X; Ding Y; Bao C; Zhu F; Hu Z; Wu M; Shen H
    Microbiol Spectr; 2021 Oct; 9(2):e0059021. PubMed ID: 34550000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of humoral immune response to different COVID-19 vaccines in patients undergoing maintenance hemodialysis.
    El-Hameed AA; Ahmed MF; Ehmemeed AOA; Mokhtar A; Abdelhamid WAR
    J Bras Nefrol; 2023; 45(4):417-423. PubMed ID: 37565727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of High Levels of Specific Humoral and Cellular Responses to SARS-CoV-2 After the Administration of Covid-19 mRNA Vaccines Requires Several Days.
    Gil-Manso S; Carbonell D; López-Fernández L; Miguens I; Alonso R; Buño I; Muñoz P; Ochando J; Pion M; Correa-Rocha R
    Front Immunol; 2021; 12():726960. PubMed ID: 34671348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular Immunity in COVID-19 Convalescents with PCR-Confirmed Infection but with Undetectable SARS-CoV-2-Specific IgG.
    Schwarzkopf S; Krawczyk A; Knop D; Klump H; Heinold A; Heinemann FM; Thümmler L; Temme C; Breyer M; Witzke O; Dittmer U; Lenz V; Horn PA; Lindemann M
    Emerg Infect Dis; 2021 Jan; 27(1):. PubMed ID: 33058753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers.
    Lustig Y; Sapir E; Regev-Yochay G; Cohen C; Fluss R; Olmer L; Indenbaum V; Mandelboim M; Doolman R; Amit S; Mendelson E; Ziv A; Huppert A; Rubin C; Freedman L; Kreiss Y
    Lancet Respir Med; 2021 Sep; 9(9):999-1009. PubMed ID: 34224675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longevity of SARS-CoV-2 immune responses in hemodialysis patients and protection against reinfection.
    Clarke CL; Prendecki M; Dhutia A; Gan J; Edwards C; Prout V; Lightstone L; Parker E; Marchesin F; Griffith M; Charif R; Pickard G; Cox A; McClure M; Tedder R; Randell P; Greathead L; Guckian M; McAdoo SP; Kelleher P; Willicombe M
    Kidney Int; 2021 Jun; 99(6):1470-1477. PubMed ID: 33774082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 antibody dynamics and B-cell memory response over time in COVID-19 convalescent subjects.
    Achiron A; Gurevich M; Falb R; Dreyer-Alster S; Sonis P; Mandel M
    Clin Microbiol Infect; 2021 Sep; 27(9):1349.e1-1349.e6. PubMed ID: 33975009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renin-angiotensin-system blockers and IgG antibodies in end-stage renal disease hemodialysis-receiving patients diagnosed with COVID-19 infection.
    Almdallaleh SA; Alsuwaida AO; Altalhi AM; ALJayar DM; Massad EE; Hamid MM; Jaganathan PP; Al-Hababi FH
    Saudi Med J; 2023 Sep; 44(9):875-881. PubMed ID: 37717960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.